Clinical Trials Browser

Neoplasm, Residual × asparaginase erwinia chrysanthemi recombinant × 1 year × Clear all

NCT07059975 2025-11-04

UPDATE AML: UPdated Disease Monitoring And Treatment for Enhanced Outcomes for Pediatric AML

Phase EARLY_PHASE1 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute, Neoplasm, Residual